@abnlab.bsky.social
📤 13
📥 36
📝 11
Official BlueSky for Dr. Anahita Bassir Nia's Adversity, Brain, Novel Therapeutics (ABN) Laboratory.
Our team is currently seeking adults who heavily drink alcohol, ages 21 to 65, for a psychedelic clinical trial. Participants are eligible for compensation up to $1,850. If interested, please call us back at 203-932-5711 x1-5314 or 203-974-7324!
6 days ago
0
1
0
Our team is currently seeking adults who heavily drink alcohol, ages 21 to 65, for a psychedelic clinical trial. Participants are eligible for compensation up to $1,850. If interested, please call us back at 203-932-5711 x1-5314 or 203-974-7324!
15 days ago
0
1
0
Our team is currently seeking adults who heavily drink alcohol, ages 21 to 65, for a psychedelic clinical trial. Participants are eligible for compensation up to $1,850. If interested, please call us back at 203-932-5711 x1-5314 or 203-974-7324!
3 months ago
0
1
0
Interested in research? Our team is currently seeking healthy volunteers age 18-60 for a psychedelic clinical trial located in New Haven, CT. Participants are eligible for compensation up to $625. If interested, please call us back at 203-974-7324!
4 months ago
0
1
0
Our team is currently seeking healthy volunteers age 18-60 for a psychedelic clinical trial located in New Haven, CT. Participants are eligible for compensation up to $625. If interested, please call us back at 203-974-7324!
5 months ago
0
1
0
Read our latest
#research
on the contribution of
#CBD
in treatment for
#opioid
#addiction
, published with @WileyGlobal in Addiction Biology on behalf of The Society for the Study of Addiction. Read here:
doi.org/10.1111/adb....
.
loading . . .
The Potential Use of Cannabidiol in the Treatment of Opioid Use Disorder: A Systematic Review
This systematic review found that CBD may reduce opioid cravings and abstinence-related anxiety in individuals with opioid use disorder. Preclinical studies also suggest CBD can reduce withdrawal sym...
https://doi.org/10.1111/adb.70047
8 months ago
0
2
1
Yale ABNLab will be presenting at SOBP 2025 in Toronto this week! Please see below for more details!
#Neuroscience
#NeuroPsych
#PsychResearch
#2025SOBP
9 months ago
0
2
1
Read our latest
#research
on the contribution of
#psychotherapy
to
#psychedelic
treatment for
#opioid
#addiction
, published with @SpringerNature in Current Addiction Reports. Read here:
rdcu.be/eaAo9
11 months ago
0
2
0
Read our latest
#research
on the contribution of
#psychotherapy
to
#psychedelic
treatment for
#opioid
#addiction
, published with
@springernature.com
in Current Addiction Reports. Read here:
rdcu.be/eaAo9
11 months ago
0
2
1
about 1 year ago
0
0
0
reposted by
Anahita Bassir Nia
about 1 year ago
Heading to
#acnp2024
to present my research on the
#endocannabinoid
system in
#opioid
use disorder.
@abnlab.bsky.social
@acnporg.bsky.social
#acnp2024
add a skeleton here at some point
0
4
1
reposted by
Anahita Bassir Nia
about 1 year ago
A pre
#acnp2024
#hike
in
#Sedona
. I hiked
#cathedralrock
,
#littlehorse
, and
#chapeltrail
. I had underestimated
#arizona
sun! But the trails were wonderful!
@acnporg.bsky.social
@abnlab.bsky.social
0
33
2
reposted by
Anahita Bassir Nia
about 1 year ago
Another poster from
@abnlab.bsky.social
with
@harpaz-rotem.bsky.social
on
#cannabinoid
receptor type 1 availability in
#ptsd
with
#childhood_trauma
today at 5pm.
#acnp2024
@acnporg.bsky.social
0
2
1
ABN Lab's Dr. Anahita Bassir Nia will be presenting the results of her NIDA-funded study on CB1R availability in opioid use disorder this upcoming Monday, December 9th at
#ACNP2024
!
about 1 year ago
0
1
1
you reached the end!!
feeds!
log in
